Net Sales (USD, millions)

Cost of Goods Sold (USD, millions)

Selling, General and Administrative Expense (USD, millions)

Operating Profit (USD, millions)

Interest Expense (USD, millions)

Other Income (Expense), Net (USD, millions)

Income Before Income Taxes (USD, millions)

Income Taxes (USD, millions)

Earnings (Loss) from Unconsolidated Entities (USD, millions)

Net Income (USD, millions)

Net Income (Loss) Attributable to Noncontrolling Interests (USD, millions)

Net Income Attributable to Kellanova (USD, millions)

9a3be5e2a8a91bc3bdd45fd03a013794f3073d67d6116127ef25b1fe98ec36e7

Net income (USD, millions)

Depreciation and amortization (USD, millions)

Impairment of property (USD, millions)

Postretirement benefit plan expense (benefit) (USD, millions)

Deferred income taxes (USD, millions)

Stock compensation (USD, millions)

Other adjustments (USD, millions)

Distribution from postretirement benefit plan (USD, millions)

Postretirement benefit plan contributions (USD, millions)

Trade receivables changes (USD, millions)

Inventories changes (USD, millions)

Accounts payable changes (USD, millions)

All other current assets and liabilities changes (USD, millions)

Net cash provided by (used in) operating activities (USD, millions)

Additions to properties (USD, millions)

Purchases of marketable securities (USD, millions)

Sales of marketable securities (USD, millions)

Settlement of net investment hedges (USD, millions)

Other investing activities (USD, millions)

Net cash provided by (used in) investing activities (USD, millions)

Net issuances (reductions) of notes payable (USD, millions)

Reductions of long-term debt (USD, millions)

Net issuances of common stock (USD, millions)

Cash dividends (USD, millions)

Other financing activities (USD, millions)

Net cash provided by (used in) financing activities (USD, millions)

Effect of exchange rate changes on cash and cash equivalents (USD, millions)

Increase (decrease) in cash and cash equivalents (USD, millions)

Cash and cash equivalents at beginning of period (USD, millions)

Cash and cash equivalents at end of period (USD, millions)

f69f56e87d8a61fe5d18c1dedad0dc874a0fc87f11b768fbf786753bcbe929e2

e3d908be69b19790c37799bf064ba337d5b3646389b756af27d9e34df377d65e

Adjustments for Non-Cash Items [USD, Millions]

Stock-Based Compensation [USD, Millions]

Changes in Working Capital [USD, Millions]

Capital Expenditures (CapEx) [USD, Millions]

Proceeds from / Repayments of Debt [USD, Millions]

Share Repurchases [USD, Millions]

Dividend Payments [USD, Millions]

Net Change in Cash [USD, Millions]

92fa935f63298e31b9f834383f189ceec0da30196aaa961ece9b2e8ddb9563fe

1f0a9b1d31f6c4ee192d7bab91081394c818811279ac76c0d7795a988b985b31

1b050e48a14c0f7c246c29800086479ae52b88de69e13a6a9e4e13950e822b54

d56cd3fa8f03abc0b04598ae4b8263b09bef121cd98ee1ac4e76bb2ac348631f

Snacks

Cereal

Frozen

Noodles and Other

- U.S. Morning Foods

- U.S. Specialty

- North America Other

- Europe

- Latin America

- Asia Pacific

Total Revenue

1e01e1e5fcdcf1f2bc91e671ee3071d44ce70d19f1f3e71aebaf8f80a54b76c7

21c0088bd05620b0c3beb672389ad28a3c41582c4b8702da2f627371493884b9

KELLANOVA (K)

Financials